PAIR Distinguished Lecture Series: Crosswalk between Engineering, Biology and Medicine
Conference / Lecture
-
Date
23 Apr 2024
-
Organiser
PolyU Academy for Interdisciplinary Research
-
Time
10:30 - 12:00
-
Venue
Lecture Theatre GH201, Podium Floor, Wing GH, PolyU Map
Speaker
Prof. CUI Zhanfeng
Enquiry
PolyU Academy for Interdisciplinary Research 3400 3036 info.pair@polyu.edu.hk
Remarks
Open to public
Summary
Biomedical engineering develops solutions to meet unmet clinical needs based on advances in science, particularly biological and life sciences. In this talk, Prof. Cui will discuss some examples to illustrate the irreplicable roles the engineers play and the critical contributions to the development of new therapies and new clinical practice. These includes:
- Tissue engineering
- Cell and stem cell therapy
- Point of care medical devices and in vitro diagnostics
- the development of novel research tools to support fundamental research in life sciences
One purpose of this talk would be to inspire next generation of engineers and scientists to consider a career in this exciting and rewarding domain.
Keynote Speaker
Prof. CUI Zhanfeng
Donald Pollock Professor of Chemical Engineering, University of Oxford and Founding Director of Oxford Suzhou Centre for Advanced Research
Professor CUI Zhanfeng is the Donald Pollock Professor of Chemical Engineering, University of Oxford since the Chair was established in 2000. He is the Founding Director of the Oxford Suzhou Centre for Advanced Research (OSCAR), the only Oxford University Centre outside the UK in Physical Sciences and Engineering. He was educated in China, and awarded BSc (1982), from Inner Mongolia Polytechnic University, MSc (1984) and PhD (1987) from Dalian University of Technology. After a postdoc in Strathclyde University (1988-1991), he became a Lecturer of Chemical Engineering in Edinburgh University in 1991, moved to Oxford in 1994 as a University Lecturer in Engineering Science and Tutorial Fellow of Keble College. He became a Reader in Engineering Science in 1999. He was elected to the first Chemical Engineering Chair at the University of Oxford in 2000 and a Professorial Fellow of Hertford College. He is a Fellow of the Institution of Chemical Engineers (FIChemE, 2003) and a Fellow of American Institute of Medical and Biological Engineering (FAIMBE, 2014). In 2009, he was awarded a Higher Doctorate, Doctor of Science (DSc), by the University of Oxford, to recognize his excellence in academic scholarship. He was elected to a Fellow of the Royal Academy of Engineering (FREng) in 2013, a Foreign Member of the Chinese Academy of Engineering in 2021, and a Fellow of the UK Academy of Medical Sciences (FMedSci), 2023. Professor CUI is known for his work on membrane technology and bioprocessing. He has focused on the interface between Chemical Engineering and Life Sciences and Medicine. His current research interests focus on the development of enabling technologies for regenerative medicine (bioreactors, three-dimensional culture, cryopreservation and scale-up), and applications to treat cancers, diabetes, neural degeneration and musculoskeletal conditions. He is also active in developing in vitro diagnostic technologies for point of care testing, in particular, of cancers and infectious diseases.
You may also like
